DrugPatentWatch Database Preview

Uswm Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for USWM, and what generic and branded alternatives to USWM drugs are available?

USWM has four approved drugs.

Summary for Uswm

US Patents:	0
Tradenames:	4
Ingredients:	4
NDAs:	4

Drugs and US Patents for Uswm

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	No
Uswm	MELPHALAN HYDROCHLORIDE	melphalan hydrochloride	INJECTABLE;INJECTION	207032-001	May 3, 2019		DISCN	No	No
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-005	Oct 28, 1986	AB	RX	Yes	No
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-004	Approved Prior to Jan 1, 1982		DISCN	No	No
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-002	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes
Uswm	LUCEMYRA	lofexidine hydrochloride	TABLET;ORAL	209229-001	May 16, 2018		RX	Yes	Yes

Expired US Patents for Uswm

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-001	Approved Prior to Jan 1, 1982	3,982,021
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-002	Approved Prior to Jan 1, 1982	3,982,021
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-003	Approved Prior to Jan 1, 1982	3,935,267
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-005	Oct 28, 1986	3,935,267
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-002	Approved Prior to Jan 1, 1982	3,935,267
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-004	Approved Prior to Jan 1, 1982	3,982,021
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-001	Approved Prior to Jan 1, 1982	3,935,267

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Uswm